AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Sarepta Therapeutics, Inc. Director's Dealing 2017

Dec 5, 2017

31721_dirs_2017-12-05_84a626e3-c6a5-40a3-a66d-725347831ad6.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Sarepta Therapeutics, Inc. (SRPT)
CIK: 0000873303
Period of Report: 2017-12-04

Reporting Person: BONNEY MICHAEL W (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
No Securities Owned	0	Direct